[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100525746":3},{"organization":4,"armGroups":7,"interventions":22,"overallOfficials":10,"centralContacts":33,"locations":39,"responsibleParty":70,"collaborators":72,"id":76,"slug":77,"hasResults":78,"nctId":79,"briefTitle":80,"officialTitle":81,"acronym":10,"eligibilityCriteria":82,"healthyVolunteers":78,"sex":83,"minAge":84,"maxAge":10,"enrollmentInfo":85,"targetDuration":10,"studyType":88,"phases":89,"briefSummary":91,"conditions":92,"keywords":94,"overallStatus":42,"whyStopped":10,"lastUpdateSubmitDate":100,"lastUpdatePostDateStruct":101,"startDateStruct":104,"completionDateStruct":106,"leadSponsor":108,"locationsCount":109},{"fullName":5,"class":6},"Abramson Cancer Center at Penn Medicine","OTHER",[8,13,18],{"label":9,"type":6,"description":10,"interventionNames":11},"Usual Care",null,[12],"Behavioral: Usual Care",{"label":14,"type":15,"description":10,"interventionNames":16},"In-Person LEF-SMP","EXPERIMENTAL",[17],"Behavioral: In-Person LEF-SMP",{"label":19,"type":15,"description":10,"interventionNames":20},"Telehealth LEF-SMP",[21],"Behavioral: Telehealth LEF-SMP",[23,27,30],{"type":24,"name":9,"description":25,"armGroupLabels":26,"otherNames":10},"BEHAVIORAL","Participants will conduct self-care activities prescribed by their treating lymphedema therapists.",[9],{"type":24,"name":14,"description":28,"armGroupLabels":29,"otherNames":10},"Participants will receive the in-person LEF-SMP intervention.",[14],{"type":24,"name":19,"description":31,"armGroupLabels":32,"otherNames":10},"Participants will receive the telehealth LEF-SMP intervention.",[19],[34],{"name":35,"role":36,"phone":37,"phoneExt":10,"email":38},"Jie Deng, PhD","CONTACT","2155732393","jiedeng@nursing.upenn.edu",[40,57],{"facility":41,"status":42,"city":43,"state":44,"zip":45,"country":46,"countryCode":47,"cosmosGeoPoint":48,"geoPoint":53,"contacts":54},"University of Pennsylvania","RECRUITING","Philadelphia","Pennsylvania","19104","United States","US",{"type":49,"coordinates":50},"Point",[51,52],-75.16362,39.95238,{"lat":52,"lon":51},[55],{"name":35,"role":36,"phone":56,"phoneExt":10,"email":38},"215-573-2393",{"facility":58,"status":42,"city":59,"state":60,"zip":61,"country":46,"countryCode":47,"cosmosGeoPoint":62,"geoPoint":66,"contacts":67},"Barbara Murphy","Nashville","Tennessee","37232",{"type":49,"coordinates":63},[64,65],-86.78444,36.16589,{"lat":65,"lon":64},[68],{"name":69,"role":36,"phone":10,"phoneExt":10,"email":10},"Barbara Murphy, MD",{"type":71,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[73],{"name":74,"class":75},"United States Department of Defense","FED","100525746","self-management-for-head-and-neck-lymphedema-and-fibrosis-promise-trial-100525746",false,"NCT06125743","Self-Management for Head and Neck Lymphedema and Fibrosis [PROMISE Trial]","Promoting Self-Management in Head and Neck Cancer Survivors With Lymphedema and Fibrosis [PROMISE Trial]","Inclusion Criteria:\n\n* \\>18 years of age\n* Post HNC primary treatment\n* No evidence of cancer (NED)\n* Completion of initial lymphedema therapy for head and neck lymphedema\n* Unable to obtain lymphedema therapy due to barriers noted above\n* History of lymphedema on the face and neck, with or without fibrosis\n* Ability to understand English in order to complete questionnaires\n* Ability to perform self-care activities for LEF management\n* Ability to provide informed consent\n* Having an electronic device (a computer, tablet, iPad, or smartphone) and internet access at home\n* A valid email address\n\nExclusion Criteria:\n\n* Recurrent or metastatic cancer\n* Any other active cancer\n* Acute infection\n* Acute congestive heart failure\n* Acute renal failure\n* Cardiac or pulmonary edema\n* Sensitive carotid sinus\n* Severe carotid blockage\n* Uncontrolled hypertension\n* Venous thrombosis\n* Pregnant people\n* Incarcerated patients","ALL","18 Years",{"count":86,"type":87},204,"ESTIMATED","INTERVENTIONAL",[90],"NA","The goal of this study is to evaluate the effectiveness of a standardized lymphedema and fibrosis self-management program (LEF-SMP) to improve LEF self-management and reduce LEF-associated symptom burden, functional deficits, and improve quality of life in head and neck cancer (HNC) survivors.",[93],"Lymphedema of the Head and Neck",[95,96,97,98,99],"Lymphedema","Fibrosis","Head and Neck Cancer","Survivorship","Self-Management","2025-08-09",{"date":102,"type":103},"2025-08-14","ACTUAL",{"date":105,"type":103},"2024-03-29",{"date":107,"type":87},"2026-08-31",{"name":5,"class":6},2]